Matt Gross

406 total citations
9 papers, 300 citations indexed

About

Matt Gross is a scholar working on Cancer Research, Oncology and Molecular Biology. According to data from OpenAlex, Matt Gross has authored 9 papers receiving a total of 300 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cancer Research, 3 papers in Oncology and 2 papers in Molecular Biology. Recurrent topics in Matt Gross's work include Cancer, Hypoxia, and Metabolism (5 papers), Cancer Research and Treatments (2 papers) and Pancreatic and Hepatic Oncology Research (1 paper). Matt Gross is often cited by papers focused on Cancer, Hypoxia, and Metabolism (5 papers), Cancer Research and Treatments (2 papers) and Pancreatic and Hepatic Oncology Research (1 paper). Matt Gross collaborates with scholars based in United States and United Kingdom. Matt Gross's co-authors include Xin Du, Elias Lolis, Jon J. Vermeire, Richard Bucala, Kirk W. Johnson, Lin Leng, Yoonsang Cho, G.V. Crichlow, Michael Cappello and F C Gaeta and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and PLoS ONE.

In The Last Decade

Matt Gross

9 papers receiving 294 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Matt Gross United States	7	108	80	73	52	28	9	300
Íngrid Martí-Pàmies Spain	12	93 0.9×	112 1.4×	100 1.4×	36 0.7×	7 0.3×	16	319
Jacob Sterling United States	13	54 0.5×	142 1.8×	31 0.4×	21 0.4×	28 1.0×	19	416
M. Deininger Germany	10	74 0.7×	155 1.9×	28 0.4×	53 1.0×	31 1.1×	18	444
Judith Alonso Spain	13	173 1.6×	141 1.8×	151 2.1×	50 1.0×	8 0.3×	26	406
Nivetha Murugesan United States	13	75 0.7×	156 1.9×	33 0.5×	28 0.5×	26 0.9×	23	494
Yirui Zhao China	9	30 0.3×	77 1.0×	58 0.8×	16 0.3×	57 2.0×	21	277
Xiaoyan Xiong China	9	94 0.9×	161 2.0×	28 0.4×	57 1.1×	6 0.2×	13	374
Likui Lu China	10	21 0.2×	154 1.9×	39 0.5×	36 0.7×	28 1.0×	30	311
Arturo Bravo‐Nuevo United States	14	54 0.5×	226 2.8×	27 0.4×	30 0.6×	21 0.8×	27	426
Guohong Gao China	8	35 0.3×	170 2.1×	36 0.5×	93 1.8×	8 0.3×	13	337

Countries citing papers authored by Matt Gross

Since Specialization

Citations

This map shows the geographic impact of Matt Gross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matt Gross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matt Gross more than expected).

Fields of papers citing papers by Matt Gross

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matt Gross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matt Gross. The network helps show where Matt Gross may publish in the future.

Co-authorship network of co-authors of Matt Gross

This figure shows the co-authorship network connecting the top 25 collaborators of Matt Gross. A scholar is included among the top collaborators of Matt Gross based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matt Gross. Matt Gross is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Emberley, Ethan, Alison Pan, Jason Chen, et al.. (2021). The glutaminase inhibitor telaglenastat enhances the antitumor activity of signal transduction inhibitors everolimus and cabozantinib in models of renal cell carcinoma. PLoS ONE. 16(11). e0259241–e0259241. 33 indexed citations

Gross, Matt. (2017). Chapter 419: Cyber Sexual Bullying, “Sexting” in Schools, and the Growing Need to Educate the Youth. Scholarly Commons (University of the Pacific). 48(3). 555–574. 3 indexed citations

Emberley, Ethan, Mark K. Bennett, Matt Gross, et al.. (2016). CB-839, a selective glutaminase inhibitor, has anti-tumor activity in renal cell carcinoma and synergizes with everolimus and receptor tyrosine kinase inhibitors. European Journal of Cancer. 69. S124–S124. 6 indexed citations

Gross, Matt, Jason Chen, Julie Janes, et al.. (2016). Abstract 2329: Glutaminase inhibition with CB-839 enhances anti-tumor activity of PD-1 and PD-L1 antibodies by overcoming a metabolic checkpoint blocking T cell activation. Cancer Research. 76(14_Supplement). 2329–2329. 16 indexed citations

MacKinnon, Andrew L., Mark K. Bennett, Matt Gross, et al.. (2015). Metabolomic, Proteomic and Genomic Profiling Identifies Biomarakers of Sensitivity to Glutaminase Inhibitor CB-839 in Multiple Myeloma. Blood. 126(23). 1802–1802. 4 indexed citations

Parlati, Francesco, Susan D. Demo, Julie Janes, et al.. (2013). Antitumor Activity Of The Glutaminase Inhibitor CB-839 In Hematological Malignances. Blood. 122(21). 4226–4226. 21 indexed citations

Watson, Jim, Florian Kern, Matt Gross, et al.. (2012). Carbon Capture and Storage Realising the potential. ORCA Online Research @Cardiff (Cardiff University). 17 indexed citations

Cho, Yoonsang, G.V. Crichlow, Jon J. Vermeire, et al.. (2010). Allosteric inhibition of macrophage migration inhibitory factor revealed by ibudilast. Proceedings of the National Academy of Sciences. 107(25). 11313–11318. 159 indexed citations

Kamat, Pradip, Atul Vats, Matt Gross, & Paul A. Checchia. (2003). Use of hypertonic saline for the treatment of altered mental status associated with diabetic ketoacidosis. Pediatric Critical Care Medicine. 4(2). 239–242. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact